Literature DB >> 15825830

Sulfur-substituted and alpha-methylated fatty acids as peroxisome proliferator-activated receptor activators.

Laila N Larsen1, Linda Granlund, Anne Kristin Holmeide, Lars Skattebøl, Hilde Irene Nebb, Jon Bremer.   

Abstract

FA with varying chain lengths and an alpha-methyl group and/or a sulfur in the beta-position were tested as peroxisome proliferator-activated receptor (PPAR)alpha, -delta(beta), and -gamma ligands by transient transfection in COS-1 cells using chimeric receptor expression plasmids, containing cDNAs encoding the ligand-binding domain of PPARalpha, -delta, and -gamma. For PPARalpha, an increasing activation was found with increasing chain length of the sulfur-substituted FA up to C14-S acetic acid (tetradecylthioacetic acid = TTA). The derivatives were poor, and nonsignificant, activators of PPARdelta. For PPARgamma, activation increased with increasing chain length up to C16-S acetic acid. A methyl group was introduced in the alpha-position of palmitic acid, TTA, EPA, DHA, cis9,trans11 CLA, and trans10,cis12 CLA. An increased activation of PPARalpha was obtained for the alpha-methyl derivatives compared with the unmethylated FA. This increase also resulted in increased expression of the two PPARalpha target genes acyl-CoA oxidase and liver FA-binding protein for alpha-methyl TTA, alpha-methyl EPA, and alpha-methyl DHA. Decreased or altered metabolism of these derivatives in the cells cannot be excluded. In conclusion, saturated FA with sulfur in the beta-position and increasing carbon chain length from C9-S acetic acid to C14-S acetic acid have increasing effects as activators of PPARalpha and -gamma in transfection assays. Furthermore, alpha-methyl FA derivatives of a saturated natural FA (palmitic acid), a sulfur-substituted FA (TTA), and PUFA (EPA, DHA, c9,t11 CLA, and t10,c12 CLA) are stronger PPARalpha activators than the unmethylated compounds.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15825830     DOI: 10.1007/s11745-005-1359-3

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  58 in total

1.  Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators.

Authors:  I Issemann; S Green
Journal:  Nature       Date:  1990-10-18       Impact factor: 49.962

2.  Microsomal oxidation of dodecylthioacetic acid (a 3-thia fatty acid) in rat liver.

Authors:  E Hvattum; S Bergseth; C N Pedersen; J Bremer; A Aarsland; R K Berge
Journal:  Biochem Pharmacol       Date:  1991 Mar 15-Apr 1       Impact factor: 5.858

3.  Phytanic acid is ligand and transcriptional activator of murine liver fatty acid binding protein.

Authors:  C Wolfrum; P Ellinghaus; M Fobker; U Seedorf; G Assmann; T Börchers; F Spener
Journal:  J Lipid Res       Date:  1999-04       Impact factor: 5.922

4.  Mitochondrial 3-hydroxy-3-methylglutaryl coenzyme A synthase and carnitine palmitoyltransferase II as potential control sites for ketogenesis during mitochondrion and peroxisome proliferation.

Authors:  L Madsen; A Garras; G Asins; D Serra; F G Hegardt; R K Berge
Journal:  Biochem Pharmacol       Date:  1999-05-01       Impact factor: 5.858

5.  Molecular modelling of the rat peroxisome proliferator-activated receptor -alpha (rPPARalpha) by homology with the human retinoic acid X receptor alpha (hRXRalpha) and investigation of ligand binding interactions I: QSARs.

Authors:  D F Lewis; B G Lake
Journal:  Toxicol In Vitro       Date:  1998-12       Impact factor: 3.500

6.  Liver fatty acid-binding protein targets fatty acids to the nucleus. Real time confocal and multiphoton fluorescence imaging in living cells.

Authors:  Huan Huang; Olga Starodub; Avery McIntosh; Ann B Kier; Friedhelm Schroeder
Journal:  J Biol Chem       Date:  2002-05-22       Impact factor: 5.157

7.  Substrate and hormone regulation of palmitoyl-CoA synthetase in 7800 C1 Morris hepatoma cells and cultured rat hepatocytes.

Authors:  P Wu; S Skrede; E Hvattum; J Bremer
Journal:  Biochim Biophys Acta       Date:  1993-10-13

8.  Subtype specific effects of peroxisome proliferator-activated receptor ligands on corepressor affinity.

Authors:  Thomas B Stanley; Lisa M Leesnitzer; Valerie G Montana; Cristin M Galardi; Millard H Lambert; Jason A Holt; H Eric Xu; Linda B Moore; Steven G Blanchard; Julie B Stimmel
Journal:  Biochemistry       Date:  2003-08-12       Impact factor: 3.162

9.  Peroxisomal beta-oxidation of branched chain fatty acids in rat liver. Evidence that carnitine palmitoyltransferase I prevents transport of branched chain fatty acids into mitochondria.

Authors:  H Singh; K Beckman; A Poulos
Journal:  J Biol Chem       Date:  1994-04-01       Impact factor: 5.157

10.  Induction of peroxisomal acyl-CoA oxidase by 3-thia fatty acid, in hepatoma cells and hepatocytes in culture is modified by dexamethasone and insulin.

Authors:  H N Sørensen; E Hvattum; E J Paulssen; K M Gautvik; J Bremer; O Spydevold
Journal:  Biochim Biophys Acta       Date:  1993-01-23
View more
  3 in total

1.  Uteroplacental insufficiency increases visceral adiposity and visceral adipose PPARgamma2 expression in male rat offspring prior to the onset of obesity.

Authors:  Lisa A Joss-Moore; Yan Wang; Michael S Campbell; Barry Moore; Xing Yu; Christopher W Callaway; Robert A McKnight; Mina Desai; Laurie J Moyer-Mileur; Robert H Lane
Journal:  Early Hum Dev       Date:  2010-03-12       Impact factor: 2.079

2.  Stable analogs of 13‑hydroxy-9,10-trans-epoxy-(11E)-octadecenoate (13,9-HEL), an oxidized derivative of linoleic acid implicated in the epidermal skin barrier.

Authors:  Gregory S Keyes; Kristen Maiden; Christopher E Ramsden
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2021-10-24       Impact factor: 4.006

3.  The PPAR pan-agonist tetradecylthioacetic acid promotes redistribution of plasma cholesterol towards large HDL.

Authors:  Thomas Lundåsen; Matteo Pedrelli; Bodil Bjørndal; Björn Rozell; Raoul V Kuiper; Lena Burri; Chiara Pavanello; Marta Turri; Jon Skorve; Rolf K Berge; Stefan E H Alexson; Veronika Tillander
Journal:  PLoS One       Date:  2020-03-16       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.